Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The viral replication pathway refers to the sequence of molecular events by which a virus enters a host cell, replicates its genetic material, produces viral proteins, assembles new virions, and releases them to infect new cells. These pathways are highly diverse across different virus classes, as described by the Baltimore classification system (e.g., dsDNA, ssRNA, retroviruses), and involve both viral and host cellular factors. Many approved antiviral drugs target specific viral enzymes within this pathway (such as RNA-dependent RNA polymerases, proteases, or integrases), or, less commonly, essential host factors involved in the process. The viral replication pathway itself is a concept, not an individual molecule or direct pharmacological target.
Inhibition of viral enzyme activity (e.g., polymerase inhibitors); Blocking viral entry or fusion; Inhibition of viral protein processing or assembly; Enhancement or modulation of host antiviral responses
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral replication pathway.